Skip to main content
Erschienen in: Wiener Medizinische Wochenschrift 5-6/2017

01.04.2017 | letter to the editor

Melanoma in situ (MIS) in a patient with atypical mole syndrome (AMS): with aggressiveness to success?

verfasst von: Prof. Dr. G. Tchernev, Dr. A. A. Chokoeva, Prof. T. Lotti, S. Philipov, MD, PhD, senior pathologist

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 5-6/2017

Einloggen, um Zugang zu erhalten

Excerpt

Dear editors, …
Literatur
1.
Zurück zum Zitat Silva JH, Sá BC, Avila AL, Landman G, Duprat Neto JP. Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma – review article. Clinics (Sao Paulo). 2011;66(3):493–9.CrossRef Silva JH, Sá BC, Avila AL, Landman G, Duprat Neto JP. Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma – review article. Clinics (Sao Paulo). 2011;66(3):493–9.CrossRef
2.
Zurück zum Zitat Akhtar S, Bhat W, Magdum A, Stanley PR. Surgical excision margins for melanoma in situ. J Plast Reconstr Aesthet Surg. 2014;67(3):320–3.CrossRefPubMed Akhtar S, Bhat W, Magdum A, Stanley PR. Surgical excision margins for melanoma in situ. J Plast Reconstr Aesthet Surg. 2014;67(3):320–3.CrossRefPubMed
3.
Zurück zum Zitat Bataille V, Bishop JA, Sasieni P, Swerdlow AJ, Pinney E, Griffiths K, Cuzick J. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer. 1996;73(12):1605–11.CrossRefPubMedPubMedCentral Bataille V, Bishop JA, Sasieni P, Swerdlow AJ, Pinney E, Griffiths K, Cuzick J. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer. 1996;73(12):1605–11.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Friedman RJ, Farber MJ, Warycha MA. The “dysplastic” nevus. Clin Dermatol. 2009;27:103–15.CrossRefPubMed Friedman RJ, Farber MJ, Warycha MA. The “dysplastic” nevus. Clin Dermatol. 2009;27:103–15.CrossRefPubMed
5.
Zurück zum Zitat Sezer E, Özturk Durmaz E, Çetin E, Şahin S. Meyerson phenomenon as a component of melanoma in situ. Acta Dermatovenerol Croat. 2016;24(1):81–2.PubMed Sezer E, Özturk Durmaz E, Çetin E, Şahin S. Meyerson phenomenon as a component of melanoma in situ. Acta Dermatovenerol Croat. 2016;24(1):81–2.PubMed
6.
Zurück zum Zitat Tchernev G, Ananiev J, Cardoso JC, Chokoeva AA, Philipov S, Penev PK, Lotti T, Wollina U. Multiple primary cutaneous melanomas in patients with FAMMM syndrome and sporadic atypical mole syndrome (AMS): what’s worse? Wien Med Wochenschr. 2014;164(15–16):302–7.CrossRefPubMed Tchernev G, Ananiev J, Cardoso JC, Chokoeva AA, Philipov S, Penev PK, Lotti T, Wollina U. Multiple primary cutaneous melanomas in patients with FAMMM syndrome and sporadic atypical mole syndrome (AMS): what’s worse? Wien Med Wochenschr. 2014;164(15–16):302–7.CrossRefPubMed
Metadaten
Titel
Melanoma in situ (MIS) in a patient with atypical mole syndrome (AMS): with aggressiveness to success?
verfasst von
Prof. Dr. G. Tchernev
Dr. A. A. Chokoeva
Prof. T. Lotti
S. Philipov, MD, PhD, senior pathologist
Publikationsdatum
01.04.2017
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 5-6/2017
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-016-0503-9

Weitere Artikel der Ausgabe 5-6/2017

Wiener Medizinische Wochenschrift 5-6/2017 Zur Ausgabe

images in science and medicine

Large basal cell carcinoma of the scalp